288 related articles for article (PubMed ID: 29251630)
1. Cancer-associated fibroblasts regulate endothelial adhesion protein LPP to promote ovarian cancer chemoresistance.
Leung CS; Yeung TL; Yip KP; Wong KK; Ho SY; Mangala LS; Sood AK; Lopez-Berestein G; Sheng J; Wong ST; Birrer MJ; Mok SC
J Clin Invest; 2018 Feb; 128(2):589-606. PubMed ID: 29251630
[TBL] [Abstract][Full Text] [Related]
2. PP2A binds to the LIM domains of lipoma-preferred partner through its PR130/B″ subunit to regulate cell adhesion and migration.
Janssens V; Zwaenepoel K; Rossé C; Petit MM; Goris J; Parker PJ
J Cell Sci; 2016 Apr; 129(8):1605-18. PubMed ID: 26945059
[TBL] [Abstract][Full Text] [Related]
3. Anticancer Immunotherapy by MFAP5 Blockade Inhibits Fibrosis and Enhances Chemosensitivity in Ovarian and Pancreatic Cancer.
Yeung TL; Leung CS; Yip KP; Sheng J; Vien L; Bover LC; Birrer MJ; Wong STC; Mok SC
Clin Cancer Res; 2019 Nov; 25(21):6417-6428. PubMed ID: 31332047
[TBL] [Abstract][Full Text] [Related]
4. CD44-Targeting PLGA Nanoparticles Incorporating Paclitaxel and FAK siRNA Overcome Chemoresistance in Epithelial Ovarian Cancer.
Byeon Y; Lee JW; Choi WS; Won JE; Kim GH; Kim MG; Wi TI; Lee JM; Kang TH; Jung ID; Cho YJ; Ahn HJ; Shin BC; Lee YJ; Sood AK; Han HD; Park YM
Cancer Res; 2018 Nov; 78(21):6247-6256. PubMed ID: 30115698
[TBL] [Abstract][Full Text] [Related]
5. The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation.
Kiepas A; Voorand E; Senecal J; Ahn R; Annis MG; Jacquet K; Tali G; Bisson N; Ursini-Siegel J; Siegel PM; Brown CM
J Biol Chem; 2020 Jul; 295(31):10535-10559. PubMed ID: 32299913
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II, focal adhesion kinase, and PRX1 enhance smooth muscle expression of lipoma preferred partner and its newly identified binding partner palladin to promote cell migration.
Jin L; Kern MJ; Otey CA; Wamhoff BR; Somlyo AV
Circ Res; 2007 Mar; 100(6):817-25. PubMed ID: 17322171
[TBL] [Abstract][Full Text] [Related]
7. The focal adhesion and nuclear targeting capacity of the LIM-containing lipoma-preferred partner (LPP) protein.
Petit MM; Meulemans SM; Van de Ven WJ
J Biol Chem; 2003 Jan; 278(4):2157-68. PubMed ID: 12441356
[TBL] [Abstract][Full Text] [Related]
8. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth.
Merritt WM; Lin YG; Spannuth WA; Fletcher MS; Kamat AA; Han LY; Landen CN; Jennings N; De Geest K; Langley RR; Villares G; Sanguino A; Lutgendorf SK; Lopez-Berestein G; Bar-Eli MM; Sood AK
J Natl Cancer Inst; 2008 Mar; 100(5):359-72. PubMed ID: 18314475
[TBL] [Abstract][Full Text] [Related]
9. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel.
Li S; Zhao X; Chang S; Li Y; Guo M; Guan Y
Int J Oncol; 2019 Jan; 54(1):249-260. PubMed ID: 30431082
[TBL] [Abstract][Full Text] [Related]
10. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
[TBL] [Abstract][Full Text] [Related]
11. CAFs-derived MFAP5 promotes bladder cancer malignant behavior through NOTCH2/HEY1 signaling.
Zhou Z; Cui D; Sun MH; Huang JL; Deng Z; Han BM; Sun XW; Xia SJ; Sun F; Shi F
FASEB J; 2020 Jun; 34(6):7970-7988. PubMed ID: 32293074
[TBL] [Abstract][Full Text] [Related]
12. Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.
Leung CS; Yeung TL; Yip KP; Pradeep S; Balasubramanian L; Liu J; Wong KK; Mangala LS; Armaiz-Pena GN; Lopez-Berestein G; Sood AK; Birrer MJ; Mok SC
Nat Commun; 2014 Oct; 5():5092. PubMed ID: 25277212
[TBL] [Abstract][Full Text] [Related]
13. Identification of key genes and pathways related to cancer-associated fibroblasts in chemoresistance of ovarian cancer cells based on GEO and TCGA databases.
Han L; Guo X; Du R; Guo K; Qi P; Bian H
J Ovarian Res; 2022 Jun; 15(1):75. PubMed ID: 35739532
[TBL] [Abstract][Full Text] [Related]
14. A complex containing LPP and α-actinin mediates TGFβ-induced migration and invasion of ErbB2-expressing breast cancer cells.
Ngan E; Northey JJ; Brown CM; Ursini-Siegel J; Siegel PM
J Cell Sci; 2013 May; 126(Pt 9):1981-91. PubMed ID: 23447672
[TBL] [Abstract][Full Text] [Related]
15. SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma.
Liu CL; Pan HW; Torng PL; Fan MH; Mao TL
Oncol Rep; 2019 Dec; 42(6):2706-2715. PubMed ID: 31638245
[TBL] [Abstract][Full Text] [Related]
16. A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43.
Nanayakkara M; Kosova R; Lania G; Sarno M; Gaito A; Galatola M; Greco L; Cuomo M; Troncone R; Auricchio S; Auricchio R; Barone MV
PLoS One; 2013; 8(11):e79763. PubMed ID: 24278174
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC.
Heenatigala Palliyage G; Samart P; Bobbala S; Rojanasakul LW; Coyle J; Martin K; Callery PS; Rojanasakul Y
Lung Cancer; 2023 Jul; 181():107258. PubMed ID: 37245409
[TBL] [Abstract][Full Text] [Related]
18. circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis.
Hu C; Xia R; Zhang X; Li T; Ye Y; Li G; He R; Li Z; Lin Q; Zheng S; Chen R
Mol Cancer; 2022 Jan; 21(1):24. PubMed ID: 35045883
[TBL] [Abstract][Full Text] [Related]
19. FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication.
Wu HJ; Hao M; Yeo SK; Guan JL
Oncogene; 2020 Mar; 39(12):2539-2549. PubMed ID: 31988451
[TBL] [Abstract][Full Text] [Related]
20. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
Steg AD; Katre AA; Goodman B; Han HD; Nick AM; Stone RL; Coleman RL; Alvarez RD; Lopez-Berestein G; Sood AK; Landen CN
Clin Cancer Res; 2011 Sep; 17(17):5674-85. PubMed ID: 21753153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
